David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), bought 20,000 shares at $20.17 ($403K) on 2021-03-30, disclosed to the SEC on 2021-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.17 | 10,000 | $202K | 50.0% |
| 2 | $20.17 | 10,000 | $202K | 50.0% |
| Total | $20.17 avg | 20,000 | $403K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |